遗传性出血性毛细血管扩张症的腹部表现:15年间333例患者系列
研究纳入2001年1月至2015年5月在本机构接受专用HHT方案多期腹部CT的333例连续HHT患者,由三名腹部放射科医师审阅图像,评估肝、胰、脾及其他腹部器官血管异常。180/333(54.1%)患者至少有一种肝脏血管异常,其中70.0%有多种肝脏血管异常;胰腺18.0%、脾6.3%、小肠4.5%。作者认为优化多期腹部CT是评估和筛查HHT患者的重要工具。
要点
- HHT患者中肝脏是最常受累的腹部器官,180/333(54.1%)至少有一种肝脏血管异常。
- 有肝脏血管异常者中70.0%存在多种肝脏血管异常,包括毛细血管扩张、融合性血管团、灌注异常和肝分流。
- 其他受累器官包括胰腺18.0%、脾6.3%、小肠4.5%,常规或单期增强CT可能低估这些表现。
核心结论
- 临床诊断HHT的患者中超过半数存在腹部血管异常,最常受累器官为肝脏,这些异常在常规或单期增强腹部CT上可能被低估,支持优化多期腹部CT作为HHT患者评估和筛查的重要工具。
研究设计与样本
- 研究类型为系列病例分析,纳入2001年1月至2015年5月在本机构接受专用HHT方案多期腹部CT的333例连续HHT患者,CT由三名委员会认证的腹部放射科医师审阅。
关键影像表现/征象
- 肝脏血管异常表现为毛细血管扩张、融合性血管团、一过性灌注异常和肝分流。
- 有腹部血管异常的患者中肝脏最常受累,180/333(54.1%)至少有一种肝脏血管异常,其中70.0%有多种肝脏血管异常。
- 其他常见受累器官为胰腺18.0%、脾6.3%、小肠4.5%。
临床应用与阅片要点
- 作者认为优化多期腹部CT是评估和筛查HHT患者的重要工具。
- 常规或单期增强腹部CT可能低估HHT相关腹部血管异常。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multi-organ vascular disorder that commonly affects the gastrointestinal tract and the liver resulting in telangiectasias and arteriovenous malformations (AVMs). Previous studies looking at the prevalence of liver and abdominal organ involvement in HHT have been limited by differing imaging techniques and sample size limitations. We sought to define the prevalence of HHT related abdominal vascular abnormalities using optimized multiphasic contrast-enhanced abdominal computed tomography (CT) exams in a large cohort of HHT patients.
METHODS: Between January 2001 and May 2015; we identified a total of 333 consecutive HHT patients who had undergone a dedicated HHT protocol multiphase abdominal CT at our institution. The CT exams were reviewed by three board certified abdominal radiologists for the presence of vascular abnormalities involving the liver, pancreas, spleen, and other abdominal organs. Vascular abnormalities involving the liver were further categorized as telangiectasias, large confluent vascular masses, perfusion abnormalities, or hepatic shunts.
RESULTS: In patients with abdominal vascular abnormalities, the liver was the most commonly involved organ, with 180 out of 333 (54.1%) patients demonstrating at least one hepatic vascular abnormality (telangiectasia, confluent vascular mass, transient perfusion abnormalities, and hepatic shunts), with most (70.0%) demonstrating multiple hepatic vascular abnormalities. The other most common organs involved included the pancreas (18.0%), spleen (6.3%), and small bowel (4.5%).
CONCLUSION: In patients with the clinical diagnosis of HHT, greater than half demonstrate an abdominal vascular abnormality, with the most commonly involved organ being the liver. These may be under recognized on routine or single phase contrast-enhanced CT of the abdomen. This supports the use of optimized multiphasic abdominal CT exams as an important tool for the evaluation and screening of patients with HHT.
引用
- Welle CL, Welch BT, Brinjikji W, et al. Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years. Abdom Radiol (NY). 2019. PMID: 30888464. doi:10.1007/s00261-019-01976-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。